4 Firms Set To Launch IPOs (Public Issue) In Coming Week
The primary market continues to be a busy one with four firms, including Archean Chemical Industries and Five Star Business Finance, are set to float their initial public offerings (IPOs) next week to collectively raise about Rs 5,000 crore.
The other two firms whose IPOs are ready to open are -- Kaynes Technology India and Inox Green Energy Services.
This came after four companies launched their initial share-sales last week. Of these, two IPOs -- maker of snacks and sweets Bikaji Foods International and Global Health Ltd which operates hospitals under the Medanta brand -- are currently underway.
The IPOs of Archean Chemical and Five Star Business will be open for public subscription on November 9 and close on November 11, while that of Kaynes Technology and Inox Green are set to kick off on November 10 and November 11 respectively, as per the red herring prospectus (RHP).
So far in 2022, as many as 26 companies have floated their IPOs to raise over Rs 48,000 crore. In 2021, 63 IPOs had mopped up over Rs 1.19 lakh crore, the data with exchanges showed.
According to market experts, volatility in the secondary market led to a weak IPO market in 2022.
Non-banking lender Five Star Business Finance's IPO is entirely an offer for sale (OFS) of shares to the tune of Rs 1,960 crore by existing shareholders and promoter group entities.
The OFS will see the sale of shares to the tune of Rs 166.74 crore by SCI Investments V, Rs 719.41 crore by Matrix Partners India Investment Holdings II LLC, Rs 12.08 crore by Matrix Partners India Investments II Extension LLC, Rs 361.44 crore by Norwest Venture Partners X- Mauritius and Rs 700.31 crore by TPG Asia VII SF Pte Ltd.
The Chennai-headquartered firm has set a price band of Rs 450-474 per equity shares. The NBFC is backed by investors like TPG, Matrix Partners, Norwest Ventures, Sequoia and KKR.
The IPO of speciality marine chemical manufacturer Archean Chemical consists of a fresh issue of equity shares aggregating up to Rs 805 crore and an offer for sale (OFS) of up to 1.61 crore shares by the promoter and investors, including the India Resurgence Fund, a joint venture between the Piramal Group and Bain Capital.
Promoter Chemikas Speciality will sell 20 lakh shares via OFS, while investors Piramal Natural Resources and India Resurgence Fund will sell 38.35 lakh shares each. India Resurgence Fund II will divest 64.78 lakh shares.
The price band has been set at Rs 386-407 a share for the issue, which is expected to fetch Rs 1,462.3 crore at the upper end of the band. The company plans to use the proceeds of the fresh issue for the redemption of non-convertible debentures (NCDs) issued by it.
The initial share-sale of Kaynes Technology, an IoT (Internet of Things) solutions-enabled integrated electronics manufacturing company, comprises fresh issue of equity shares worth Rs 530 crore and an OFS of up to 55.85 lakh equity shares by a promoter and an existing shareholder.
The OFS comprises sale of 20.84 lakh equity shares by promoter Ramesh Kunhikannan and 35 lakh equity shares by existing shareholder Freny Firoze Irani.
According to merchant banking sources, the issue is expected to mop up over Rs 850 crore.
Proceeds from the fresh issue will be used to repay debt, funding capital expenditure for its manufacturing facilities at Mysore and Manesar and funding working capital requirements. Also, the company plans to invest in its arm Kaynes Electronics Manufacturing for setting up a new facility at Chamarajanagar in Karnataka.
The Rs 740-crore IPO of Inox Green, an arm of Inox Wind, comprises a fresh issue and an offer for sale of Rs 370 crore each. The issue will open on November 11 and close on November 15.
Proceeds from the fresh issue will be utilised for repaying debts and general corporate purposes.
The equity shares of the four companies will be listed on the BSE and NSE.Â
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.